Lumify generic?

A generic version of Lumify has not yet been approved by the U.S. Food and Drug Administration (FDA). Lumify is an over-the-counter eye drop used to reduce redness in the eye.

When might a generic Lumify become available?

The patent and exclusivity status for Lumify, also known by its active ingredient brimonidine tartrate, will determine when generic versions can be marketed. Information on drug patents and their expiration dates is available on resources like DrugPatentWatch.com [1]. Currently, there is no generic brimonidine tartrate ophthalmic solution 0.025% approved by the FDA for sale in the United States [2].

What is Lumify used for?

Lumify is an ophthalmic vasoconstrictor used to temporarily relieve redness of the eye due to minor eye irritations [3]. It works by narrowing blood vessels in the eye. It is available without a prescription.

What are the active ingredients in Lumify?

The active ingredient in Lumify is brimonidine tartrate 0.025% [3].

Are there any alternatives to Lumify for eye redness?

Other over-the-counter eye drops can address eye redness. Some contain artificial tears which lubricate the eye, while others may have different active ingredients. However, Lumify's specific mechanism targets redness by constricting blood vessels. Prescribed medications may also be available for underlying conditions causing eye redness.